Archive - February 2021
Synairgen’s inhaled COVID-19 treatment included in US trial
NIHR funds study aiming to improve the lives of people with cystic fibrosis
US approval for Libtayo in advanced basal cell carcinoma
ViiV’s Rukobia wins EU authorisation to treat multidrug-resistant HIV
AstraZeneca/Oxford University’s COVID-19 vaccine set for UK rollout
FDA considers new safety warnings for Pfizer’s JAK inhibitor Xeljanz
Janssen’s Erleada improves survival in certain advanced prostate cancer patients
EU orders another 300 million doses of Pfizer/BioNTech’s COVID-19 vaccine